Physician profile
Ellen E Eighmy
NPI 1245071836
$2,847.62
in general payments reported to CMS, 2019-2025
18 companies · $1,849 in 2025
The $1,849 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $998 · 2025: $1,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.64 |
| Education | $134.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $343.65 | 2024-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $307.18 | 2025 | Sotyktu |
| Pfizer INC. | $297.76 | 2024-2025 | |
| Lilly USA, LLC | $277.61 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Abbvie INC. | $276.16 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $257.25 | 2024-2025 | Libtayo, Dupixent |
| Janssen Biotech, INC. | $234.13 | 2024-2025 | Tremfya |
| Genzyme Corporation | $145.56 | 2024-2025 | |
| Galderma Laboratories, L.P. | $139.51 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $135.89 | 2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $94.13 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $75.95 | 2025 | |
| Leo Pharma INC. | $62.31 | 2024-2025 | Adbry |
| Incyte Corporation | $54.14 | 2025 | Opzelura |
| Amgen INC. | $45.64 | 2024-2025 | Otezla, Otezla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $42.15 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.95 | 2024-2025 | Jublia, Cabtreo, Arazlo |
| Helsinn Therapeutics (U.S.), INC. | $16.65 | 2025 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Eighmy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.